Abstract
Cigarette smoking has been strongly established as a major cause of cardiovascular disease (CVD) [1,2]. For example, women smoking as few as 1 to 4 cigarettes per day are at 2.5 times the risk of fatal cardiovascular disease (CVD) and nonfatal myocardial infarction compared to nonsmokers. Elimination of smoking can produce a substantial reduction in premature morbidity and mortality. Estimates indicate that up to 30%, or 170,000, of all coronary heart disease (CHD) deaths in the United States each year are attributable to cigarette smoking, with the risk being strongly dose-related [2]. In addition, smoking acts synergistically with other risk factors, substantially increasing the risk of CVD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
U.S. Department of Health and Human Services. The health consequences of smoking: Cardiovascular disease: A report of the Surgeon General. Rockville, MD: Office on Smoking and Health, 1983. (vol Publication PHS 84–50204).
U.S. Department of Health and Human Services. The health benefits of smoking cessation: A report of the Surgeon General. Washington, DC: U.S. Govt Printing Office, (CDC)90–8416, 1990.
Doll R, Peto R Mortality in relation to smoking. Twenty years’ observations on male British doctors. Br Med J 1976; 2: 1525 – 36.
Friedman G, Petitti D, Bawal R, et al. Mortality in cigarette smokers and quitters: Effect of baseline differences. N Engl J Med 1981; 304: 1407 – 10.
Ockene J, Kuller L, Svendsen K, Meilahn E. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 1990; 80: 954 – 58.
Centers for Disease Control and Prevention. Smoking-attributable mortality and years of potential life lost – United States, 1990. MMWR 1993; 42 (33): 645 – 48.
Fiore M, Novotny T, Pierce J, et al. Methods used to quit smoking in the United States: Do cessation programs help? JAMA 1990; 263 (20): 2760 – 65.
U.S. Department of Health and Human Services. Current estimates from the National Health Interview Survey, 1993 (Series 10: Data from the National Health Survey No. 190). Hyattsville, MD: Public Health Service, Centers for Disease Control, National Center for Health Statistics, 1994.
Ockene J. Physician-delivered interventions for smoking cessation: Strategies for increasing effectiveness. Prey Med 1987; 16: 723 – 37.
Ockene I, Ockene J, editors. Prevention of Coronary Heart Disease. Boston: Little, Brown and Company, 1992.
Fiore M, Bailey W, Cohen S, et al. Smoking cessation: Clinical practice guideline No. 18. Rockville, MD: U.S. Department of Public Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996.
Ockene J, McBride P, Sallis J, Bonollo D, Ockene I. Synthesis of lessons learned from cardiopulmonary preventive interventions in healthcare practice settings. Ann Epidemiol In press.
Ockene J, Kristeller J, Goldberg R, et al. Smoking cessation and severity of disease: The Coronary Artery Smoking Intervention Study. Hlth Psychol 1992; 11 (2): 119 – 26.
DeBusk R, Houston Miller N, Superko H, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Annals of Intern Med 1994; 120: 721 – 29.
Frid D, Ockene I, Ockene J, et al. Severity of angiographically proven coronary artery disease predicts smoking cessation. Am J Prey Med 1991; 7 (3): 131 – 35.
Rose G, Hamilton P. A randomized controlled trial of the effect of middle-aged men of advice to stop smoking. J Epidemiol Community Health 1982; 36: 102 – 8.
Rosenstock I. The Health Belief Model: Explaining health behavior through expectancies. In: Glanz K, Lewis F, Rimer R, editors. Health behavior and health education: Theory, research, and practice. San Francisco: Jossey Bass, 1990.
Bandura A. Self-Efficacy: The exercise of control. New York: WH Freeman and Company, 1997: 604.
Marlatt A, Gordon J, McClellan W. Current perspectives: Patient education in medical practice. Patient Ed Couns 1986; 8: 151 – 63.
Prochaska J, DiClemente C. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consulting and Clinical Psychology 1983; 51: 390 – 95.
Ockene J. Smoking intervention: A behavioral, educational, and pharmacologie perspective. In: Ockene I, Ockene J, editors. Prevention of coronary heart disease. Boston: Little, Brown and Company, 1992: 201 – 30.
Ockene J, Quirk M, Goldberg R, et al. A residents training program for the development of smoking intervention skills. Arch hit Med 1988; 148: 1039 – 45.
Ockene J, Bonollo D, Adams A. Smoking and coronary artery disease in women: Diagnosis and management in the context of women’s lives. In press.
Division of Preventive and Behavioral Medicine. Healthcare provider smoking intervention training: Workshop participant manual. In: Massachusetts Tobacco Control Program, Dept. of Public Health. Worcester, MA: University of Massachusetts Medical School, 1994.
Glynn T, Manley M. How to help your patients stop smoking. Bethesda: National Institutes of Health, National Cancer Institute, 1993.
Ockene J, Kristeller J, Goldberg R, et al. Increasing the efficacy of physician-delivered smoking intervention: A randomized clinical trial. J Gen Intern Med 1991; 6: 1 – 8.
Fagerstrom K. Measuring degree of physical dependency to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3: 235 – 41.
Heatherton T, Kozlowski L, Frecker R, Fagerstrom K. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. Brit J Addiction 1991; 86 (9): 1119 – 27.
Foxy R, Brown R. Nicotine fading and self-monitoring for cigarette abstinence or controlled smoking. J Appl Behav Anal 1979; 12: 111 – 25.
Lam W, Sze P, Sacks H, Chalmers T. Meta-analysis of randomized controlled trials of nicotine chewing gum. Lancet 1987; 2: 27 – 29.
Schneider N, Olmstead R, Mody F, et al. Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial. Addiction 1995; 90: 1671 – 82.
Perry L, Robbins A, Scariati P, et al. Enhancement of smoking cessation using the antidepressant bupropion hydrochloride. Abstract. Circulation 1992; 86: 671.
Robinson M, Laurent S, Little J. Including smoking status as a new vital sign: It works! J Fam Pract 1995; 40 (6): 556 – 63.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Ockene, J.K., Ockene, I.S. (1998). Preventing Cardiovascular Disease: Effective Smoking Cessation Strategies for the Busy Clinician. In: Gotto, A.M., Lenfant, C., Paoletti, R., Catapano, A.L., Jackson, A.S. (eds) Multiple Risk Factors in Cardiovascular Disease. Medical Science Symposia Series, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5022-4_35
Download citation
DOI: https://doi.org/10.1007/978-94-011-5022-4_35
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6108-7
Online ISBN: 978-94-011-5022-4
eBook Packages: Springer Book Archive